CDSCO flags 26 formulations as not of standard quality
Advertisement
In the latest drug safety alert, the apex drug regulatory body, the Central Drug Standard Control Organisation (CDSCO) has flagged 26 medicine batches for failing to qualify for random drug sample tests for the month of June.
These drugs samples which are declared not standard quality include Hindustan Antibiotics' Ibuprofen Tablets, Swiss Garnier Biotech's Cyfolac Forte (Prebiotic & Probiotics Capsules), Oxalis Labs's Salmeterol and Fluticasone Propionate, Shine Pharmaceuticals's Atorvastatin Calcium, Healer's Lab's Albendazole and others.
For more details, check out the full story on the link below:
Drug Alert: CDSCO Flags 26 Formulations As Not Of Standard Quality
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.